{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T01:59:21Z","timestamp":1772935161139,"version":"3.50.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Folia Microbiol"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s12223-025-01366-1","type":"journal-article","created":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T10:47:35Z","timestamp":1760352455000},"page":"1-11","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A comprehensive review on antifungal compounds and biogenic nanoparticles from marine actinobacteria against opportunistic fungal infections"],"prefix":"10.1007","volume":"71","author":[{"given":"Apsara S.","family":"Babu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6327-1452","authenticated-orcid":false,"given":"K. V. Bhaskara","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,13]]},"reference":[{"key":"1366_CR1","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.ejar.2016.05.004","volume":"42","author":"HM Abd-Elnaby","year":"2016","unstructured":"Abd-Elnaby HM, Abo-Elala GM, Abdel-Raouf UM et al (2016) Antibacterial and anticancer activity of extracellular synthesized silver nanoparticles from marine Streptomyces rochei MHM13. Egypt J Aquat Res 42:301\u2013312. https:\/\/doi.org\/10.1016\/j.ejar.2016.05.004","journal-title":"Egypt J Aquat Res"},{"key":"1366_CR2","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1007\/s11705-016-1599-6","volume":"10","author":"M Abirami","year":"2016","unstructured":"Abirami M, Kannabiran K (2016) Streptomyces ghanaensis VITHM1 mediated green synthesis of silver nanoparticles: mechanism and biological applications. Front Chem Sci Eng 10:542\u2013551. https:\/\/doi.org\/10.1007\/s11705-016-1599-6","journal-title":"Front Chem Sci Eng"},{"key":"1366_CR3","doi-asserted-by":"publisher","unstructured":"Abou El-Enain IM, Abed NN, Helal EE et al (2022) Ecofriendly biosynthesis of Ag-NPs by Streptomyces griseus eradicating Candida albicans associated with different types of dysspermatism (preprint). Research Square. https:\/\/doi.org\/10.21203\/rs.3.rs-1730237\/v1","DOI":"10.21203\/rs.3.rs-1730237\/v1"},{"key":"1366_CR4","doi-asserted-by":"publisher","first-page":"813","DOI":"10.3390\/antibiotics9110813","volume":"9","author":"CS Ahamefule","year":"2020","unstructured":"Ahamefule CS, Ezeuduji BC, Ogbonna JC et al (2020) Marine bioactive compounds against Aspergillus fumigatus: challenges and future prospects. Antibiot 9:813. https:\/\/doi.org\/10.3390\/antibiotics9110813","journal-title":"Antibiot"},{"key":"1366_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/wasj.2024.237","volume":"6","author":"A Ahmad","year":"2024","unstructured":"Ahmad A, Haneef M, Ahmad N et al (2024) Biological synthesis of silver nanoparticles and their medical applications. World Acad Sci J 6:1\u20139. https:\/\/doi.org\/10.3892\/wasj.2024.237","journal-title":"World Acad Sci J"},{"key":"1366_CR6","doi-asserted-by":"crossref","unstructured":"Ambavane V, Tokdar P, Parab R et al (2014) Caerulomycin A-An antifungal compound isolated from marine actinomycetes. Adv Microbiol 4:567\u2013578. http:\/\/drs.nio.org\/drs\/handle\/2264\/4590.\u00a0Accessed 4 Oct 2025","DOI":"10.4236\/aim.2014.49063"},{"key":"1366_CR7","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3390\/jof6030138","volume":"6","author":"A Arastehfar","year":"2020","unstructured":"Arastehfar A, Lass-Fl\u00f6rl C, Garcia-Rubio R et al (2020) The quiet and underappreciated rise of drug-resistant invasive fungal pathogens. J Fungi 6:138. https:\/\/doi.org\/10.3390\/jof6030138","journal-title":"J Fungi"},{"key":"1366_CR8","doi-asserted-by":"publisher","first-page":"ofae372","DOI":"10.1093\/ofid\/ofae372","volume":"11","author":"MC Arendrup","year":"2024","unstructured":"Arendrup MC, Armstrong-James D, Borman AM et al (2024) The impact of the fungal priority pathogens list on medical mycology: a Northern European perspective. Open Forum Infect Dis 11:ofae372. https:\/\/doi.org\/10.1093\/ofid\/ofae372","journal-title":"Open Forum Infect Dis"},{"key":"1366_CR9","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1007\/s11164-016-2766-6","volume":"43","author":"B Balraj","year":"2017","unstructured":"Balraj B, Senthilkumar N, Siva C et al (2017) Synthesis and characterization of zinc oxide nanoparticles using marine Streptomyces sp. with its investigations on anticancer and antibacterial activity. Res Chem Intermed 43:2367\u20132376. https:\/\/doi.org\/10.1007\/s11164-016-2766-6","journal-title":"Res Chem Intermed"},{"key":"1366_CR10","doi-asserted-by":"publisher","first-page":"106005","DOI":"10.1016\/j.ijantimicag.2020.106005","volume":"56","author":"F Barbosa","year":"2020","unstructured":"Barbosa F, Pinto E, Kijjoa A et al (2020) Targeting antimicrobial drug resistance with marine natural products. Int J Antimicrob Agents 56:106005. https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.106005","journal-title":"Int J Antimicrob Agents"},{"key":"1366_CR11","doi-asserted-by":"publisher","first-page":"348","DOI":"10.3390\/md22080348","volume":"22","author":"D Bharathi","year":"2024","unstructured":"Bharathi D, Lee J (2024) Recent advances in marine-derived compounds as potent antibacterial and antifungal agents: a comprehensive review. Mar Drugs 22:348. https:\/\/doi.org\/10.3390\/md22080348","journal-title":"Mar Drugs"},{"key":"1366_CR12","doi-asserted-by":"publisher","first-page":"5856","DOI":"10.3390\/molecules25245856","volume":"25","author":"J Cardoso","year":"2020","unstructured":"Cardoso J, Nakayama DG, Sousa E et al (2020) Marine-derived compounds and prospects for their antifungal application. Molecules 25:5856. https:\/\/doi.org\/10.3390\/molecules25245856","journal-title":"Molecules"},{"key":"1366_CR13","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1111\/j.1751-7915.2010.00179.x","volume":"3","author":"A Debbab","year":"2010","unstructured":"Debbab A, Aly AH, Lin WH et al (2010) Bioactive compounds from marine bacteria and fungi. Microb Biotechnol 3:544\u2013563. https:\/\/doi.org\/10.1111\/j.1751-7915.2010.00179.x","journal-title":"Microb Biotechnol"},{"key":"1366_CR14","first-page":"7","volume":"15","author":"D Dhanasekaran","year":"2008","unstructured":"Dhanasekaran D, Thajuddin N, Panneerselvam A (2008) An antifungal compound: 4\u2032 phenyl-1-napthyl\u2013phenyl acetamide from Streptomyces sp. dptb16. Facta Univ Ser Med Biol 15:7\u201312","journal-title":"Facta Univ Ser Med Biol"},{"key":"1366_CR15","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1007\/s11274-010-0415-6","volume":"26","author":"S Dharmaraj","year":"2010","unstructured":"Dharmaraj S (2010) Marine Streptomyces as a novel source of bioactive substances. World J Microbiol Biotechnol 26:2123\u20132139. https:\/\/doi.org\/10.1007\/s11274-010-0415-6","journal-title":"World J Microbiol Biotechnol"},{"key":"1366_CR16","first-page":"1020","volume":"7","author":"AI El-Batal","year":"2015","unstructured":"El-Batal AI, Al Tamie MS (2015) Biosynthesis of gold nanoparticles using marine Streptomyces cyaneus and their antimicrobial, antioxidant and antitumor (in vitro) activities. J Chem Pharm Res 7:1020\u20131036","journal-title":"J Chem Pharm Res"},{"key":"1366_CR17","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.ejmech.2016.11.022","volume":"126","author":"EM El-Hossary","year":"2017","unstructured":"El-Hossary EM, Cheng C, Hamed MM et al (2017) Antifungal potential of marine natural products. Eur J Med Chem 126:631\u2013651. https:\/\/doi.org\/10.1016\/j.ejmech.2016.11.022","journal-title":"Eur J Med Chem"},{"key":"1366_CR18","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3390\/pharmaceutics12010029","volume":"12","author":"C Faustino","year":"2020","unstructured":"Faustino C, Pinheiro L (2020) Lipid systems for the delivery of amphotericin B in antifungal therapy. Pharmaceutics 12:29. https:\/\/doi.org\/10.3390\/pharmaceutics12010029","journal-title":"Pharmaceutics"},{"key":"1366_CR19","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.micres.2012.02.008","volume":"167","author":"X Gao","year":"2012","unstructured":"Gao X, Lu Y, Xing Y et al (2012) A novel anticancer and antifungus phenazine derivative from a marine actinomycete BM-17. Microbiol Res 167:616\u2013622. https:\/\/doi.org\/10.1016\/j.micres.2012.02.008","journal-title":"Microbiol Res"},{"key":"1366_CR20","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s10295-010-0882-7","volume":"38","author":"O Genilloud","year":"2011","unstructured":"Genilloud O, Gonz\u00e1lez I, Salazar O et al (2011) Current approaches to exploit actinomycetes as a source of novel natural products. J Ind Microbiol Biotechnol 38:375\u2013389. https:\/\/doi.org\/10.1007\/s10295-010-0882-7","journal-title":"J Ind Microbiol Biotechnol"},{"key":"1366_CR21","doi-asserted-by":"publisher","first-page":"1568899","DOI":"10.3389\/fmicb.2025.1568899","volume":"16","author":"NR Helmi","year":"2025","unstructured":"Helmi NR (2025) Exploring the diversity and antimicrobial potential of actinomycetes isolated from different environments in Saudi Arabia: a systematic review. Front Microbiol 16:1568899. https:\/\/doi.org\/10.3389\/fmicb.2025.1568899","journal-title":"Front Microbiol"},{"key":"1366_CR22","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3390\/metabo10030106","volume":"10","author":"J Hou\u0161\u0165","year":"2020","unstructured":"Hou\u0161\u0165 J, Sp\u00ed\u017eek J, Havl\u00ed\u010dek V (2020) Antifungal drugs. Metabolites 10:106. https:\/\/doi.org\/10.3390\/metabo10030106","journal-title":"Metabolites"},{"key":"1366_CR23","doi-asserted-by":"publisher","first-page":"857","DOI":"10.2217\/nnm-2020-0482","volume":"16","author":"M Jafari","year":"2021","unstructured":"Jafari M, Abolmaali SS, Tamaddon AM et al (2021) Nanotechnology approaches for delivery and targeting of amphotericin B in fungal and parasitic diseases. Nanomedicine 16:857\u2013877. https:\/\/doi.org\/10.2217\/nnm-2020-0482","journal-title":"Nanomedicine"},{"key":"1366_CR24","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1111\/myc.13148","volume":"63","author":"JD Jenks","year":"2020","unstructured":"Jenks JD, Cornely OA, Chen SC et al (2020) Breakthrough invasive fungal infections: who is at risk? Mycoses 63:1021\u20131032. https:\/\/doi.org\/10.1111\/myc.13148","journal-title":"Mycoses"},{"key":"1366_CR25","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.5958\/0974-360X.2015.00273.5","volume":"8","author":"N Kamarudheen","year":"2015","unstructured":"Kamarudheen N, George CS, Pathak S et al (2015) Antagonistic activity of marine Streptomyces sp. on fish pathogenic Vibrio species isolated from aquatic environment. Res J Pharm Technol 8:1529\u20131533","journal-title":"Res J Pharm Technol"},{"key":"1366_CR26","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.nano.2013.02.002","volume":"9","author":"L Karthik","year":"2013","unstructured":"Karthik L, Kumar G, Keswani T et al (2013) Marine actinobacterial mediated gold nanoparticles synthesis and their antimalarial activity. Nanomedicine 9:951\u2013960. https:\/\/doi.org\/10.1016\/j.nano.2013.02.002","journal-title":"Nanomedicine"},{"key":"1366_CR27","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s00449-013-0994-3","volume":"37","author":"L Karthik","year":"2014","unstructured":"Karthik L, Kumar G, Kirthi AV et al (2014) Streptomyces sp. LK3 mediated synthesis of silver nanoparticles and its biomedical application. Bioprocess Biosyst Eng 37:261\u2013267. https:\/\/doi.org\/10.1007\/s00449-013-0994-3","journal-title":"Bioprocess Biosyst Eng"},{"key":"1366_CR28","doi-asserted-by":"publisher","first-page":"833154","DOI":"10.3389\/fmicb.2022.833154","volume":"13","author":"MA Khalil","year":"2022","unstructured":"Khalil MA, El-Shanshoury AE, Alghamdi MA et al (2022) Streptomyces catenulae as a novel marine actinobacterium mediated silver nanoparticles: characterization, biological activities, and proposed mechanism of antibacterial action. Front Microbiol 13:833154. https:\/\/doi.org\/10.3389\/fmicb.2022.833154","journal-title":"Front Microbiol"},{"key":"1366_CR29","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3390\/md13010128","volume":"13","author":"R Lacret","year":"2015","unstructured":"Lacret R, Oves-Costales D, G\u00f3mez C et al (2015) New ikarugamycin derivatives with antifungal and antibacterial properties from Streptomyces zhaozhouensis. Mar Drugs 13:128\u2013140. https:\/\/doi.org\/10.3390\/md13010128","journal-title":"Mar Drugs"},{"key":"1366_CR30","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.mib.2006.03.004","volume":"9","author":"KS Lam","year":"2006","unstructured":"Lam KS (2006) Discovery of novel metabolites from marine actinomycetes. Curr Opin Microbiol 9:245\u2013251. https:\/\/doi.org\/10.1016\/j.mib.2006.03.004","journal-title":"Curr Opin Microbiol"},{"key":"1366_CR31","doi-asserted-by":"publisher","first-page":"e00140","DOI":"10.1128\/CMR.00140-18","volume":"33","author":"JP Latg\u00e9","year":"2019","unstructured":"Latg\u00e9 JP, Chamilos G (2019) Aspergillus fumigatus and aspergillosis in 2019. Clin Microbiol Rev 33:e00140-18. https:\/\/doi.org\/10.1128\/CMR.00140-18","journal-title":"Clin Microbiol Rev"},{"key":"1366_CR32","doi-asserted-by":"publisher","first-page":"2894","DOI":"10.1038\/ncomms3894","volume":"4","author":"Y Luo","year":"2013","unstructured":"Luo Y, Huang H, Liang J et al (2013) Activation and characterization of a cryptic polycyclic tetramate macrolactam biosynthetic gene cluster. Nat Commun 4:2894. https:\/\/doi.org\/10.1038\/ncomms3894","journal-title":"Nat Commun"},{"key":"1366_CR33","doi-asserted-by":"publisher","unstructured":"M Hamed M, S Abdelftah L (2019) Biosynthesis of gold nanoparticles using marine Streptomyces griseus isolate (M8) and evaluating its antimicrobial and anticancer activity. Egypt J of Aquat Biol Fish 23:173\u2013184. https:\/\/doi.org\/10.21608\/ejabf.2019.26508","DOI":"10.21608\/ejabf.2019.26508"},{"key":"1366_CR34","doi-asserted-by":"publisher","first-page":"7520","DOI":"10.1128\/AEM.70.12.7520-7529.2004","volume":"70","author":"NA Magarvey","year":"2004","unstructured":"Magarvey NA, Keller JM, Bernan V et al (2004) Isolation and characterization of novel marine-derived actinomycete taxa rich in bioactive metabolites. Appl Environ Microbiol 70:7520\u20137529. https:\/\/doi.org\/10.1128\/AEM.70.12.7520-7529.2004","journal-title":"Appl Environ Microbiol"},{"key":"1366_CR35","doi-asserted-by":"publisher","first-page":"287638","DOI":"10.1155\/2013\/287638","volume":"1","author":"P Manivasagan","year":"2013","unstructured":"Manivasagan P, Venkatesan J, Senthilkumar K et al (2013) Biosynthesis, antimicrobial and cytotoxic effect of silver nanoparticles using a novel Nocardiopsis sp. MBRC-1. Biomed Res Int 1:287638. https:\/\/doi.org\/10.1155\/2013\/287638","journal-title":"Biomed Res Int"},{"key":"1366_CR36","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.micres.2013.07.014","volume":"169","author":"P Manivasagan","year":"2014","unstructured":"Manivasagan P, Venkatesan J, Sivakumar K et al (2014) Pharmaceutically active secondary metabolites of marine actinobacteria. Microbiol Res 169:262\u2013278. https:\/\/doi.org\/10.1016\/j.micres.2013.07.014","journal-title":"Microbiol Res"},{"key":"1366_CR37","doi-asserted-by":"publisher","first-page":"3566","DOI":"10.1039\/C9QO00685K","volume":"6","author":"X Mei","year":"2019","unstructured":"Mei X, Lan M, Cui G et al (2019) Caerulomycins from Actinoalloteichus cyanogriseus WH1-2216-6: isolation, identification and cytotoxicity. Org Chem Front 6:3566\u20133574. https:\/\/doi.org\/10.1039\/C9QO00685K","journal-title":"Org Chem Front"},{"key":"1366_CR38","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jiph.2018.09.005","volume":"12","author":"S Priyanka","year":"2019","unstructured":"Priyanka S, Jayashree M, Shivani R et al (2019) Characterisation and identification of antibacterial compound from marine actinobacteria: in vitro and in silico analysis. J Infect Public Health 12:83\u201389. https:\/\/doi.org\/10.1016\/j.jiph.2018.09.005","journal-title":"J Infect Public Health"},{"key":"1366_CR39","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.compbiomed.2012.01.007","volume":"42","author":"S Saha","year":"2012","unstructured":"Saha S, Priyadharshini A, Dhanasekaran D et al (2012) Preclinical evaluation and molecular docking of 4-phenyl-1-napthyl phenyl acetamide (4P1NPA) from Streptomyces sp. DPTB16 as a potent antifungal compound. Comput Biol Med 42:542\u2013547. https:\/\/doi.org\/10.1016\/j.compbiomed.2012.01.007","journal-title":"Comput Biol Med"},{"key":"1366_CR40","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1049\/iet-nbt.2015.0094","volume":"10","author":"SR Sathish Kumar","year":"2016","unstructured":"Sathish Kumar SR, Bhaskara Rao KV (2016) Postprandial anti-hyperglycemic activity of marine Streptomyces coelicoflavus SRBVIT13 mediated gold nanoparticles in streptozotocin induced diabetic male albino Wister rats. IET Nanobiotechnol 10:308\u2013314. https:\/\/doi.org\/10.1049\/iet-nbt.2015.0094","journal-title":"IET Nanobiotechnol"},{"key":"1366_CR41","doi-asserted-by":"publisher","first-page":"14281","DOI":"10.4414\/smw.2016.14281","volume":"146","author":"Y Schmiedel","year":"2016","unstructured":"Schmiedel Y, Zimmerli S (2016) Common invasive fungal diseases: an overview of invasive candidiasis, aspergillosis, cryptococcosis, and pneumocystis pneumonia. Swiss Med Wkly 146:14281. https:\/\/doi.org\/10.4414\/smw.2016.14281","journal-title":"Swiss Med Wkly"},{"key":"1366_CR42","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.tibtech.2016.02.006","volume":"34","author":"P Singh","year":"2016","unstructured":"Singh P, Kim YJ, Zhang D et al (2016) Biological synthesis of nanoparticles from plants and microorganisms. Trends Biotechnol 34:588\u2013599. https:\/\/doi.org\/10.1016\/j.tibtech.2016.02.006","journal-title":"Trends Biotechnol"},{"key":"1366_CR43","doi-asserted-by":"publisher","first-page":"2626","DOI":"10.2174\/1381612825666190709221710","volume":"25","author":"P Sivasankar","year":"2019","unstructured":"Sivasankar P, Poongodi S, Seedevi P et al (2019) Nanoparticles from actinobacteria: a potential target to antimicrobial therapy. Curr Pharm des 25:2626\u20132636. https:\/\/doi.org\/10.2174\/1381612825666190709221710","journal-title":"Curr Pharm des"},{"key":"1366_CR44","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1007\/s12088-008-0052-z","volume":"48","author":"R Solanki","year":"2008","unstructured":"Solanki R, Khanna M, Lal R (2008) Bioactive compounds from marine actinomycetes. Indian J Microbiol 48:410\u2013431. https:\/\/doi.org\/10.1007\/s12088-008-0052-z","journal-title":"Indian J Microbiol"},{"key":"1366_CR45","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ijpharm.2017.03.019","volume":"523","author":"GM Soliman","year":"2017","unstructured":"Soliman GM (2017) Nanoparticles as safe and effective delivery systems of antifungal agents: achievements and challenges. Int J Pharm 523:15\u201332. https:\/\/doi.org\/10.1016\/j.ijpharm.2017.03.019","journal-title":"Int J Pharm"},{"key":"1366_CR46","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s11046-020-00462-9","volume":"185","author":"G Song","year":"2020","unstructured":"Song G, Liang G, Liu W (2020) Fungal co-infections associated with global COVID-19 pandemic: a clinical and diagnostic perspective from China. Mycopathologia 185:599\u2013606. https:\/\/doi.org\/10.1007\/s11046-020-00462-9","journal-title":"Mycopathologia"},{"key":"1366_CR47","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s10876-022-02256-z","volume":"34","author":"A Tauseef","year":"2023","unstructured":"Tauseef A, Hisam F, Hussain T et al (2023) Nanomicrobiology: emerging trends in microbial synthesis of nanomaterials and their applications. J Clust Sci 34:639\u2013664. https:\/\/doi.org\/10.1007\/s10876-022-02256-z","journal-title":"J Clust Sci"},{"key":"1366_CR48","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1542\/pir.26-1-20","volume":"26","author":"ET Tay","year":"2005","unstructured":"Tay ET, Adam HM, Duong M et al (2005) Azole antifungal agents. Pediatr Rev 26:20\u201333. https:\/\/doi.org\/10.1542\/pir.26-1-20","journal-title":"Pediatr Rev"},{"key":"1366_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fmars.2014.00012","volume":"1","author":"L Terra","year":"2014","unstructured":"Terra L, Abreu PA, Teixeira VL et al (2014) Mycoses and antifungals: reviewing the basis of a current problem that still is a biotechnological target for marine products. Front Mar Sci 1:12. https:\/\/doi.org\/10.3389\/fmars.2014.00012","journal-title":"Front Mar Sci"},{"key":"1366_CR50","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.mycmed.2013.04.005","volume":"23","author":"M Thenmozhi","year":"2013","unstructured":"Thenmozhi M, Kannabiran K, Kumar R et al (2013) Antifungal activity of Streptomyces sp. VITSTK7 and its synthesized Ag2O\/Ag nanoparticles against medically important Aspergillus pathogens. J Mycol Med 23:97\u2013103. https:\/\/doi.org\/10.1016\/j.mycmed.2013.04.005","journal-title":"J Mycol Med"},{"key":"1366_CR51","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.biopha.2016.12.086","volume":"87","author":"SS Ul Hassan","year":"2017","unstructured":"Ul Hassan SS, Shaikh AL (2017) Marine actinobacteria as a drug treasure house. Biomed Pharmacother 87:46\u201357. https:\/\/doi.org\/10.1016\/j.biopha.2016.12.086","journal-title":"Biomed Pharmacother"},{"key":"1366_CR52","doi-asserted-by":"publisher","first-page":"539","DOI":"10.3390\/md22120539","volume":"22","author":"S Um","year":"2024","unstructured":"Um S, Jeong H, Park JE et al (2024) Isolation and characterization of bioactive compounds from Saccharomonospora sp. CMS18 and their antifungal properties. Mar Drugs 22:539. https:\/\/doi.org\/10.3390\/md22120539","journal-title":"Mar Drugs"},{"key":"1366_CR53","first-page":"583","volume":"45","author":"S Veena","year":"2016","unstructured":"Veena S, Swetha D, Karthik L et al (2016) Antibiofouling activity of marine actinobacterial mediated titanium dioxide nanoparticles. Indian J Geo-Mar Sci 45:583\u2013590","journal-title":"Indian J Geo-Mar Sci"},{"key":"1366_CR54","first-page":"919","volume-title":"Medical Microbiology","author":"TJ Walsh","year":"1996","unstructured":"Walsh TJ, Dixon DM (1996) Spectrum of mycoses. In: Baron S (ed) Medical Microbiology, 4th edn. University of Texas Medical Branch, Galveston, pp 919\u2013925","edition":"4"},{"key":"1366_CR55","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.2147\/IJN.S121956","volume":"12","author":"L Wang","year":"2017","unstructured":"Wang L, Hu C, Shao L (2017) The antimicrobial activity of nanoparticles: present situation and prospects for the future. Int J Nanomedicine 12:1227\u20131249. https:\/\/doi.org\/10.2147\/IJN.S121956","journal-title":"Int J Nanomedicine"},{"key":"1366_CR56","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s11274-017-2406-3","volume":"34","author":"M Wypij","year":"2018","unstructured":"Wypij M, Czarnecka J, \u015awiecimska M et al (2018) Synthesis, characterization and evaluation of antimicrobial and cytotoxic activities of biogenic silver nanoparticles synthesized from Streptomyces xinghaiensis OF1 strain. World J Microbiol Biotechnol 34:23. https:\/\/doi.org\/10.1007\/s11274-017-2406-3","journal-title":"World J Microbiol Biotechnol"},{"key":"1366_CR57","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jconrel.2016.01.008","volume":"224","author":"H Zazo","year":"2016","unstructured":"Zazo H, Colino CI, Lanao JM (2016) Current applications of nanoparticles in infectious diseases. J Control Release 224:86\u2013102. https:\/\/doi.org\/10.1016\/j.jconrel.2016.01.008","journal-title":"J Control Release"},{"key":"1366_CR58","doi-asserted-by":"publisher","first-page":"691","DOI":"10.3389\/fmicb.2019.00691","volume":"10","author":"J Zhang","year":"2019","unstructured":"Zhang J, Li L, Lv Q et al (2019) The fungal CYP51s: their functions, structures, related drug resistance, and inhibitors. Front Microbiol 10:691. https:\/\/doi.org\/10.3389\/fmicb.2019.00691","journal-title":"Front Microbiol"},{"key":"1366_CR59","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1093\/qjmed\/hcm035","volume":"100","author":"OS Zmeili","year":"2007","unstructured":"Zmeili OS, Soubani AO (2007) Pulmonary aspergillosis: a clinical update. QJM 100:317\u2013334. https:\/\/doi.org\/10.1093\/qjmed\/hcm035","journal-title":"QJM"}],"container-title":["Folia Microbiologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12223-025-01366-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12223-025-01366-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12223-025-01366-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T07:22:48Z","timestamp":1772868168000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12223-025-01366-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,13]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["1366"],"URL":"https:\/\/doi.org\/10.1007\/s12223-025-01366-1","relation":{},"ISSN":["0015-5632","1874-9356"],"issn-type":[{"value":"0015-5632","type":"print"},{"value":"1874-9356","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,13]]},"assertion":[{"value":"7 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants or animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}